Convert Pharmaceuticals logo

Convert Pharmaceuticals SA

Convert Pharmaceuticals SA develops hypoxia-activated cytotoxic small molecules for cancer treatment.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.convertpharma.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Quai Banning 6B-4000
Lige
Sweden
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/convertpharma” connections=”true” suffix=””]